|Organisation size||Micro (<10 employees and ≤ € 2 m turnover)|
|Market Presence||European; International (other than Europe)|
|National reach||The total number of approved ESH Centres of Excellence is 196 (15 of them are associated centres). The Centres of Excellence are located in 36 European countries and the associated centres in 8 non-European countries (Argentina, Australia, Bahrain, Brazil, Israel, Lebanon, People’s Republic of China and Venezuela).|
EUROPEAN SOCIETY OF HYPERTENSION HISTORY The main purpose of the European Society of Hypertension (ESH) is to provide a stable and organised European platform for scientific exchange in hypertension. Professor Alberto Zanchetti and his colleagues initiated a series of European Hypertension Meetings in Milan in the years when the ISH did not hold any scientific meetings. Initially, these were organised without the help and support of a scientific society, except for the 1987 meeting which was organised under the endorsement and cooperation of ISH. The so-called “Milan Meetings” proved to be enormously successful, blending high-quality science and excellent organisation with a friendly academic atmosphere of the Milan University. The Milan Meetings were very well-attended, perhaps because of the clear emphasis towards clinical hypertension research. The need for a European Society of Hypertension (ESH) was demonstrated by the success of the Milan Meetings, among other factors. The ESH was created in 1989. Thus, the 4th European Hypertension Meeting in Milan was the first to be organised under the auspices of the ESH. Much effort was given to make the ESH a true sister society of the ISH, and thus its by-laws and objectives were modeled after those of the ISH. Close cooperation between the two societies has existed since the ESH was first formed. For example, all European members of the ISH were automatically granted membership in the ESH, if desired. The Journal of Hypertension, the official journal of the ISH, was adopted by the ESH as its official journal. The links with the ISH were of course very close also on a personal level. Professor Willem Birkenhäger, the first president of the ESH, had served as vice-president of the ISH just a few years previously. Professor John Reid, the second president of the ESH, was a member of the scientific council of the ISH. Professors Alberto Zanchetti, Lennart Hansson, Peter van Zwieten and Giuseppe Mancia all served as presidents of the ESH, and had previously served as presidents of the ISH. A positive, high level of interest in the ESH continues to be exhibited. Members and European Hypertension Specialists come from all countries in Europe including all former Eastern European Countries, and from North Africa and the Middle East. The annual scientific meetings continue to grow, with increasing numbers of attendees and abstract submissions. Thus, beginning in the year 2000, the ESH decided to hold annual meetings, rather than bi-annual. The annual meeting is held in Milan every second year (in odd-numbered years) and in other European cities on alternate (even-numbered) years. However, if an ISH meeting is to be held in Europe, it is likely that the ISH and the ESH meetings will be arranged jointly for that year. This will be the case in 2020, when the two meetings will be organised together in Glasgow.
|Areas of expertise||
Annual Meeting Highlights Proceedings from the Annual European Hypertension Meetings are posted each year during and immediately following the congress. To see a listing of proceedings, select a meeting from below. Joint Meeting ESH – ISH 2020 The next Joint Meeting of the European Society of Hypertension (ESH) and International Society of Hypertension (ISH) will be held in Glasgow, UK, from May 30 to June 1, 2020. The main focus of the next Joint ESH-ISH meeting is to develop an outstanding scientific programme that will include multiple State-of-the-Art Lectures, Debates and Round Tables on issues of major… Read more » 29th European Meeting on Hypertension and Cardiovascular Protection The European Society of Hypertension (ESH) developed an outstanding scientific programme, that included multiple State-of-the-Art Lectures, Debates and Round Tables on issues on major current interest and controversy. As in the past, the program reserved a wide space to the practical aspects of the management of hypertension via Teaching, How-to, Meet the Expert and Clinical case sessions as well as… Read more » 28th European Meeting on Hypertension and Cardiovascular Protection The European Society of Hypertension (ESH) developed an outstanding scientific programme, that included multiple State-of-the-Art Lectures, Debates and Round Tables on issues on major current interest and controversy. As in the past, the program reserved a wide space to the practical aspects of the management of hypertension via Teaching, How-to, Meet the Expert and Clinical case sessions as well as… Read more » 27th European Meeting on Hypertension and Cardiovascular Protection The 4-day meeting was filled with exciting Oral Presentations, PosterPresentations, Award Lectures and Plenary Sessions that offered the unique opportunity to share ideas and participate in the interactive discussions and great debates on various aspects of hypertensive disease and cardiovascular protection. Interviews – interviews with ESH Leadership Teaching Seminars – focusing on problems in hypertensive patients seen in daily practice in an excellent educational format with many take-home… Read more » 26th European Meeting on Hypertension and Cardiovascular Protection The meeting covered a large area of knowledge in the field not only of hypertension but also of other cardiovascular and metabolic disorders related to hypertension. Particular attention was paid to new technologies, such as innovative devices, new communicating tools and biological “omics” research. Interviews – interviews with ESH Leadership Teaching Seminars – focusing on problems in hypertensive patients seen in daily.
|Areas of cooperation sought||
Development of telemedecine for early diagnosis and follow up of patients with hypertension
|Willing to share further information under a Non-Disclosure Agreement||Yes.|